Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17 Genitourinary 8 Other hematologic neoplasm 6 Classical hematology 6 CNS 3 Thoracic 2 Lymphoid 2 Endocrine 2 Sarcoma 1 Plasma cell 1 Myeloid 1 Gynecologic 1

Conditions

Sarcoma 1336 Glioblastoma 493 Gliosarcoma 470 Osteosarcoma 363 Brain Neoplasms 321 Central Nervous System Neoplasms 276 Astrocytoma 262 Dendritic Cell Sarcoma, Interdigitating 258 Gastrointestinal Stromal Tumors 251 Neoplasms 231 Glioma 229 Lymphoma 226 Neuroblastoma 209 Rhabdomyosarcoma 208 Breast Neoplasms 204 Sarcoma, Ewing 202 Recurrence 202 Burkitt Lymphoma 198 Lymphoma, Non-Hodgkin 196 Precursor Cell Lymphoblastic Leukemia-Lymphoma 195 Oligodendroglioma 192 Melanoma 182 Ovarian Neoplasms 175 Lymphoma, Large B-Cell, Diffuse 173 Neoplasm Metastasis 172 Bone Neoplasms 168 Lymphoma, Follicular 158 Leukemia, Lymphocytic, Chronic, B-Cell 144 Lymphoma, Mantle-Cell 143 Liposarcoma 143

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemorrhage × Sarcoma × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡